TSX:RVX

Resverlogix Stock Predictions

etoro logo Buy RVX
*Your capital is at risk
$0.100
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RVX.TO Prediction Chart

RVX.TO Predictions History

Latest community submissions for RVX.TO.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Apr 5, 2022 $0.469 +1.96% $0.460 X 98.04% 0
Apr 5, 2022 Bullish $0.460 X 0
Nov 28, 2019 $1.26 -4.55% $1.33 X 94.74% 0
JS JS Pro
Nov 28, 2019 $1.26 -4.55% $1.33 X 94.74% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RVX.TO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RESVERLOGIX CORP.
Resverlogix
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a part...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE